| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |